Author:
Fu Shengxiang,Cai Zhongyuan,Gu Haojie,Lui Su,Ai Hua,Song Bin,Wu Min
Funder
West China Hospital, Sichuan University
China Postdoctoral Science Foundation
Sichuan University
Natural Science Foundation of Sichuan Province
Reference48 articles.
1. Construction of smart manganese dioxide-based all-in-one nanoplatform for cancer diagnosis and therapy;Liu;Small Methods,2020
2. Zwitterion-coated ultrasmall MnO nanoparticles enable highly sensitive T1-weighted contrast-enhanced brain imaging;Wei;ACS Appl. Mater. Interfaces,2022
3. B. Ding, P. Zheng, P.a. Ma, J. Lin, Manganese oxide nanomaterials: synthesis, properties, and theranostic applications, Adv. Mater. 32(10) (2020) 1905823.
4. MnO2-based nanoplatform serves as drug vehicle and MRI contrast agent for cancer theranostics;Zhang;ACS Appl. Mater. Interfaces,2017
5. Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles;Na;Angew. Chem. Int. Ed.,2007